Article Versions Notes

Forté S, De Luna G, Abdulrehman J, Fadiga N, Pestrin O, Pham Hung d’Alexandry d’Orengiani A-L, Aneke JC, Guillet H, Budhram D, Habibi A, et al. Thromboprophylaxis Reduced Venous Thromboembolism in Sickle Cell Patients with Central Venous Access Devices: A Retrospective Cohort Study. Journal of Clinical Medicine. 2022; 11(5):1193. https://doi.org/10.3390/jcm11051193

Forté, Stéphanie, Gonzalo De Luna, Jameel Abdulrehman, Nafanta Fadiga, Olivia Pestrin, Anne-Laure Pham Hung d’Alexandry d’Orengiani, John Chinawaeze Aneke, Henri Guillet, Dalton Budhram, Anoosha Habibi, and et al. 2022. "Thromboprophylaxis Reduced Venous Thromboembolism in Sickle Cell Patients with Central Venous Access Devices: A Retrospective Cohort Study" Journal of Clinical Medicine 11, no. 5: 1193. https://doi.org/10.3390/jcm11051193

Forté, S., De Luna, G., Abdulrehman, J., Fadiga, N., Pestrin, O., Pham Hung d’Alexandry d’Orengiani, A.-L., Aneke, J. C., Guillet, H., Budhram, D., Habibi, A., Ward, R., Bartolucci, P., & Kuo, K. H. M. (2022). Thromboprophylaxis Reduced Venous Thromboembolism in Sickle Cell Patients with Central Venous Access Devices: A Retrospective Cohort Study. Journal of Clinical Medicine, 11(5), 1193. https://doi.org/10.3390/jcm11051193